Global Women's Health Diagnostics Market 2017-2021

This market research study identifies Abbott Laboratories, F. Hoffmann-La Roche, Hologic, and Siemens Healthineers as the leading players in the global women's health diagnostics market. A comprehensive analysis of this market is also presented by the application (UTIs, osteoporosis, cancer, and gynecology and fertility), end-user (hospitals, clinical diagnostic laboratories, ASCs, and home-care settings), and geography (the Americas, APAC, and EMEA).

Global women's health diagnostics market forecast

According to the women's health diagnostics industry analysis, the global women's health diagnostics market is expected to grow at a steady rate and post a CAGR of close to 7% during the forecast period. The availability of reimbursement policies for human papillomavirus (HPV) tests will drive the prospects for the global women's health diagnostics market growth from 2017 to 2021. The market is witnessing a high adoption of diagnostic products due to the growing reimbursement policies in the Americas and EMEA region. Also, the manufacturers in APAC are increasingly focusing on the development of low-cost products and conducting cervical cancer screening programs that will push the market’s growth in the coming years. The medical regulatory authorities have recommended Medicaid and private healthcare in Maryland, Texas, New Mexico, West Virginia, North Carolina, and California to cover HPV testing in the US, which will further boost the adoption rate of women's health diagnostics products in the market.

Get A Free Sample 

The Americas was the major contributor to the women's health diagnostics market in 2016 and will continue to hold the maximum share for the next four years. Factors such as the changing consumer habits, the high consumption of alcohol, and the rise in the number of diabetes and osteoporosis cases, will fuel the market’s growth in the region. Technological advancements in home-care settings for pre-natal and pregnancy tests will also drive the market’s growth in the region. 

Competitive landscape and key vendors

The women's health diagnostics market is characterized by the presence of a large number of vendors and is highly competitive. These vendors are increasingly competing against each other based on factors such as product innovation, product differentiation, pricing, and distribution partnerships. The growing focus of several vendors on product differentiation, advancement in technology, and the introduction of products in home-care settings will intensify the competitive environment of the market. Moreover, indulging in distribution partnerships and mergers and acquisitions will further strengthen the competitive environment among the market players.

Key vendors in this market are 

• Abbott Laboratories
• F. Hoffmann-La Roche
• Hologic
• Siemens Healthineers

Other prominent vendors in the market include ACON Laboratories, Alere, Becton Dick Bulleted List Propertiesinson, bioMérieux, Bio-Rad Laboratories, Carl Zeiss Meditec, Cepheid, Danaher, Illumina, Mindray, Natera, Sysmex, Thermo Fisher Scientific, and Urit Medical.

Segmentation by application and analysis of the women's health diagnostics market

• UTIs
• Osteoporosis
• Cancer
• Gynecology and fertility

The women's health cancer testing segment dominated the women's health diagnostics market during 2016 and will maintain its dominance over the projected period. Breast, cervical, and ovarian cancer are the three types of cancer covering women's health diagnostics test. The emergence of biomarker technology is pushing the preference for cancer screening, which will positively impact the women's health cancer testing segment. The segment will further grow with the increasing introduction of diagnostic test kits and home-care setting products in the market.

Segmentation by end user and analysis of the women's health diagnostics market

• Hospitals
• Clinical diagnostic laboratories
• ASCs
• Home-care settings

During 2016, the hospitals segment accounted for the majority market share and will continue to hold the largest market share during the coming years as well. Factors such as the availability of medical coverage for breast cancer screening and the availability of well-equipped advanced technologies and devices and diagnostic kits in bulk will encourage women to undergo regular health check-ups, which will propel the growth of the women's health diagnostics market.

Want a bigger picture? Try a FREE sample of this report now!

See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from this report.   

Key questions answered in the report include

• What will the market size and the growth rate be in 2021?
• What are the key factors driving the global women's health diagnostics market?
• What are the key market trends impacting the growth of the global women's health diagnostics market?
• What are the challenges to market growth?
• Who are the key vendors in the global women's health diagnostics market?
• What are the market opportunities and threats faced by the vendors in the global women's health diagnostics market?
• What are the trending factors influencing the market shares of the Americas, APAC, and EMEA?
• What are the key outcomes of the five forces analysis of the global women's health diagnostics market?

Technavio also offers customization on reports based on specific client requirement.